Non-standardised data generation and capture workflows often hinder efforts to apply machine learning in small molecule optimization. In this case study, Daniel Baeschlin shares how Novartis is systematically addressing these challenges to enable more consistent, machine-readable lab data.
Attendees will gain insights into:
Check out the incredible speaker line-up to see who will be joining Daniel.
Download The Latest Agenda